Patent 7879558 was granted and assigned to Torrey Pines Institute for Molecular Studies on February, 2011 by the United States Patent and Trademark Office.
This invention relates to the diagnosis and monitoring of ischemia, including but not limited to myocardial and cerebral ischemia, by measuring the concentration of molecules that do not originate from the ischemic tissue but whose concentration in the blood and other fluids changes as a consequence of the ischemic state.